Brief: Neuphoria Therapeutics Confirms Discussions On Potential Acquisition By Scancell
26/06/2026 21:41
BRIEF-Neuphoria Therapeutics Confirms Discussions On Potential Acquisition By Scancell June 26 (Reuters) - Neuphoria Therapeutics Inc NEUP.O:
NEUPHORIA THERAPEUTICS - IN TALKS WITH SCANCELL ABOUT POSSIBLE COMBINATION
NEUPHORIA THERAPEUTICS - CONFIRMS DISCUSSIONS ON POTENTIAL ACQUISITION BY SCANCELL, WHICH WOULD BECOME NASDAQ-LISTED
Source text: ID:nGNX5X6Vp4
Further company coverage: NEUP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Neuphoria Therapeutics
See all newsBrief: Scancell And Neuphoria Therapeutics Announce Merger Agreement And Financing
NASDAQ RESUMED AT 03:25 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 03:20 PM
Brief: Neuphoria Therapeutics Confirms Discussions On Potential Acquisition By Scancell
Brief: Neuphoria Responds To Lynx1’S Revised Indication Of Interest At A Reduced Price And Premium